In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake

Peptides

Volumn 37, Issue 2, 2012, Pages 320-326

  Xu, Shiming ^a   Han, Pei ^a   Huang, Mei ^a   Wu, Joseph C ^a   Chang, Chingpin ^a   Tsao, Philip S ^a   Yue, Patrick ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMPK; Apelin; Glucose uptake; Heart; IRS 1

Indexed keywords

APELIN; APELIN 13; FLUORODEOXYGLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE 1; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EX VIVO STUDY; GLUCOSE TRANSPORT; HEART MUSCLE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; CELL LINE; GLUCOSE TRANSPORTER TYPE 4; HEART; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIUM; PHOSPHORYLATION; RATS;

MUS;

EID: 84865472301     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.08.004     Document Type: Article

References (46)

1. E.A. Ashley, J. Powers, M. Chen, R. Kundu, T. Finsterbach, and A. Caffarelli The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Cardiovasc Res 65 2005 73 82
2. C. Attane, D. Daviaud, C. Dray, R. Dusaulcy, M. Masseboeuf, and D. Prevot Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo J Mol Endocrinol 46 2011 21 28
3. C. Attane, C. Foussal, S. Le Gonidec, A. Benani, D. Daviaud, and E. Wanecq Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice Diabetes 61 2012 310 320
4. M.F. Berry, T.J. Pirolli, V. Jayasankar, J. Burdick, K.J. Morine, and T.J. Gardner Apelin has in vivo inotropic effects on normal and failing hearts Circulation 110 2004 II187 II193
5. J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne, and A. Mazzucotelli Apelin, a newly identified adipokine up-regulated by insulin and obesity Endocrinology 146 2005 1764 1771
6. I. Castan-Laurell, M. Vitkova, D. Daviaud, C. Dray, M. Kovacikova, and Z. Kovacova Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ Eur J Endocrinol 158 2008 905 910
7. S.M. Chandra, H. Razavi, J. Kim, R. Agrawal, R.K. Kundu, and V. de Jesus Perez Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension Arterioscler Thromb Vasc Biol 31 2011 814 820
8. C.M. Cox, S.L. D'Agostino, M.K. Miller, R.L. Heimark, and P.A. Krieg Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo Dev Biol 296 2006 177 189
9. R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O'Grady, E.T. Lee, and T.K. Welty Impact of diabetes on cardiac structure and function: the strong heart study Circulation 101 2000 2271 2276
10. C. Dray, C. Knauf, D. Daviaud, A. Waget, J. Boucher, and M. Buleon Apelin stimulates glucose utilization in normal and obese insulin-resistant mice Cell Metab 8 2008 437 445
11. B. Draznin Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin Diabetes 55 2006 2392 2397
12. M. Gottlicher, E. Widmark, Q. Li, and J.A. Gustafsson Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor Proc Natl Acad Sci USA 89 1992 4653 4657
13. J. Ha, S. Daniel, S.S. Broyles, and K.H. Kim Critical phosphorylation sites for acetyl-CoA carboxylase activity J Biol Chem 269 1994 22162 22168
14. C.T. Hang, J. Yang, P. Han, H.L. Cheng, C. Shang, and E. Ashley Chromatin regulation by Brg1 underlies heart muscle development and disease Nature 466 2010 62 67
15. M.V. Heinonen, A.K. Purhonen, P. Miettinen, M. Paakkonen, E. Pirinen, and E. Alhava Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding Regul Pept 130 2005 7 13
16. N. Horike, H. Takemori, Y. Katoh, J. Doi, L. Min, and T. Asano Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2 J Biol Chem 278 2003 18440 18447
17. M. Hosoya, Y. Kawamata, S. Fukusumi, R. Fujii, Y. Habata, and S. Hinuma Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin J Biol Chem 275 2000 21061 21067
18. S.N. Jakobsen, D.G. Hardie, N. Morrice, and H.E. Tornqvist 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside J Biol Chem 276 2001 46912 46916
19. A.G. Japp, N.L. Cruden, D.A. Amer, V.K. Li, E.B. Goudie, and N.R. Johnston Vascular effects of apelin in vivo in man J Am Coll Cardiol 52 2008 908 913
20. A. Kasai, Y. Ishimaru, T. Kinjo, T. Satooka, N. Matsumoto, and Y. Yoshioka Apelin is a crucial factor for hypoxia-induced retinal angiogenesis Arterioscler Thromb Vasc Biol 30 2010 2182 2187
21. L. Li, G. Yang, Q. Li, Y. Tang, M. Yang, and H. Yang Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects Exp Clin Endocrinol Diabetes 114 2006 544 548
22. B. Masri, B. Knibiehler, and Y. Audigier Apelin signalling: a promising pathway from cloning to pharmacology Cell Signal 17 2005 415 426
23. B. Masri, H. Lahlou, H. Mazarguil, B. Knibiehler, and Y. Audigier Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein Biochem Biophys Res Commun 290 2002 539 545
24. B. Masri, N. Morin, M. Cornu, B. Knibiehler, and Y. Audigier Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells FASEB J 18 2004 1909 1911
25. 2+ channel in a rat heart muscle cell line J Physiol 478 Pt 2 1994 315 329
26. P. Melgar-Lesmes, G. Casals, M. Pauta, J. Ros, V. Reichenbach, and R. Bataller Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells Endocrinology 151 2010 5306 5314
27. C. Menard, S. Pupier, D. Mornet, M. Kitzmann, J. Nargeot, and P. Lory Modulation of l-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells J Biol Chem 274 1999 29063 29070
28. G.F. Merrill, E.J. Kurth, D.G. Hardie, and W.W. Winder AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle Am J Physiol 273 1997 E1107 E1112
29. National Diabetes Fact Sheet: general information and national estimates on diabetes in the United States, 2011; 2011.
30. B.F. O'Dowd, M. Heiber, A. Chan, H.H. Heng, L.C. Tsui, and J.L. Kennedy A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11 Gene 136 1993 355 360
31. L.Y. Qiao, R. Zhande, T.L. Jetton, G. Zhou, and X.J. Sun In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents J Biol Chem 277 2002 26530 26539
32. C. Ringstrom, M.D. Nitert, H. Bennet, M. Fex, P. Valet, and J.F. Rehfeld Apelin is a novel islet peptide Regul Pept 162 2010 44 51
33. R.R. Russell 3rd, R. Yin, M.J. Caplan, X. Hu, J. Ren, and G.I. Shulman Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo Circulation 98 1998 2180 2186
34. C.M. Schannwell, M. Schneppenheim, S. Perings, G. Plehn, and B.E. Strauer Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy Cardiology 98 2002 33 39
35. A.Y. Sheikh, H.J. Chun, A.J. Glassford, R.K. Kundu, I. Kutschka, and D. Ardigo In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure Am J Physiol Heart Circ Physiol 294 2008 H88 H98
36. J.C. Simpkin, D.M. Yellon, S.M. Davidson, S.Y. Lim, A.M. Wynne, and C.C. Smith Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury Basic Res Cardiol 102 2007 518 528
37. M. Sorhede Winzell, C. Magnusson, and B. Ahren The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice Regul Pept 131 2005 12 17
38. I. Szokodi, P. Tavi, G. Foldes, S. Voutilainen-Myllyla, M. Ilves, and H. Tokola Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility Circ Res 91 2002 434 440
39. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, and M.X. Zou Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochem Biophys Res Commun 251 1998 471 476
40. A. Tzatsos, and P.N. Tsichlis Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794 J Biol Chem 282 2007 18069 18082
41. 2+]i transient and contractions during twitches in isolated rat cardiac myocytes Am J Physiol Heart Circ Physiol 294 2008 H2540 H2546
42. R.M. Witteles, and M.B. Fowler Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options J Am Coll Cardiol 51 2008 93 102
43. P. Yue, T. Arai, M. Terashima, A.Y. Sheikh, F. Cao, and D. Charo Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse Am J Physiol Heart Circ Physiol 292 2007 H2106 H2118
44. P. Yue, H. Jin, M. Aillaud, A.C. Deng, J. Azuma, and T. Asagami Apelin is necessary for the maintenance of insulin sensitivity Am J Physiol Endocrinol Metab 298 2010 E59 E67
45. P. Yue, H. Jin, S. Xu, M. Aillaud, A.C. Deng, and J. Azuma Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms Endocrinology 152 2011 59 68
46. S. Zhu, F. Sun, W. Li, Y. Cao, C. Wang, and Y. Wang Apelin stimulates glucose uptake through the PI3 K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes Mol Cell Biochem 353 2011 305 313